ANNE Limb
Sibel Health · Decision date Nov 5, 2026
What did the FDA decide?
The FDA's 510(k) database records K261870 for the device named ANNE Limb, submitted by Sibel Health of Chicago, Illinois. The record lists the device classification name as Oximeter under regulation 870.2700, with primary product code DQA and subsequent product codes DRG and FLL. The regulation medical specialty and review panel are both recorded as Cardiovascular, and the submission type is Traditional, with no third-party review, no combination product designation and no authorized predetermined change control plan.
The application was received on 06/04/2026 and decided on 11/05/2026 as Substantially Equivalent (SESE), which is a 510(k) clearance rather than a premarket approval. The page does not state which predicate device was used, what the specific component or changed item was, or what indications the clearance covers; those details would need the underlying decision documents. The page was last updated 11/16/2026.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 5, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261870
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Sibel Health
- Product code
- DQA
- Decision code
- SESE
- Decision date
- Nov 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Oximeter.
- Applicant
- Sibel Health
- Product code
- DQA
- FDA device class
- 2
FDA decision timeline
K261870 received
Application receipt date recorded by FDA.
K261870 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DQA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Ninenovo Technology Limited | 510(k) clearance | Oct 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sibel Health
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Chicago, IL
Sources and methodology
- Original FDA record: K261870
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records